The CAPAPAF Study

• Research type

  Research Study

• Full title

  Cardioversion or Ablation or Pace and Ablate for Persistent Atrial Fibrillation: The CAPAPAF Study

• IRAS ID

  195936

• Contact name

  R A Veasey

• Contact email

  rick.veasey@nhs.net

• Sponsor organisation

  Research and Development Manager

• Clinicaltrials.gov Identifier

  NCT02528604

• Duration of Study in the UK

  1 years, 2 months, 0 days

• Research summary

  The purpose of the study is to assess different treatments for patients suffering with 'irregular heartbeats' or atrial fibrillation (AF): (1) DC cardioversion which involves returning the heart to normal rhythm using an electric shock (2) Pacemaker and AV node ablation which allows a pacemaker to take control of the heartbeat and (3) AF ablation which aims to cure AF by burning tiny areas of the heart responsible for AF. All three options are recognised treatments for AF but it is not known which provides the greatest benefits. We aim to do this by comparing the three treatments head to head.

• REC name

  London - Brighton & Sussex Research Ethics Committee

• REC reference

  16/LO/0142

• Date of REC Opinion

  11 Feb 2016

• REC opinion

  Unfavourable Opinion